Evidence map›Paper›PMID 26184139›Full record

ArticleMolecules (Basel, Switzerland)2015

Acerogenin A from Acer nikoense Maxim Prevents Oxidative Stress-Induced Neuronal Cell Death through Nrf2-Mediated Heme Oxygenase-1 Expression in Mouse Hippocampal HT22 Cell Line.

Dong-Sung Lee, Byung-Yoon Cha, Je-Tae Woo, Youn-Chul Kim, Jun-Hyeog Jang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Dihydropashanone Isolated fromInternational journal of molecular sciences · 2024
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Dong-Sung LeeDepartment of Biomedical Chemistry, College of Health and Biomedical Science, Konkuk University, Chung-Ju 380-701, Korea. dslee@kku.ac.kr.
Byung-Yoon ChaResearch Institute for Biological Functions, Chubu University, 1200 Matsumoto, Kasugai, Aichi 487-8501, Japan. bycha@isc.chubu.ac.jp.
Je-Tae WooResearch Institute for Biological Functions, Chubu University, 1200 Matsumoto, Kasugai, Aichi 487-8501, Japan. jwoo@isc.chubu.ac.jp.
Youn-Chul KimCollege of Pharmacy, Wonkwang University, Iksan 570-749, Korea. yckim@wku.ac.kr.
Jun-Hyeog JangDepartment of Biochemistry, Inha University School of Medicine, Incheon 400-712, Korea. juhjang@inha.ac.kr.
Chubu University · JPInha University · KRKonkuk University · KRWonkwang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative cell damage contributes to neuronal degeneration in many central nervous system (CNS) diseases such as Parkinson's disease, Alzheimer's disease, and ischemia. Inducible heme oxygenase (HO)-1 acts against oxidants that are thought to play a key role in the pathogenesis of neuronal diseases. The stem bark of Acer nikoense Maxim (Aceraceae) is indigenous to Japan; it has been used in folk medicine as a treatment of hepatic disorders and eye diseases. Acerogenin A, a natural compound isolated from Japanese folk medicine A. nikoense, showed neuroprotective effects and reactive oxygen species (ROS) reduction on glutamate-induced neurotoxicity by inducing the expression of HO-1 in mouse hippocampal HT22 cells. Furthermore, acerogenin A caused the nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and the activation of the PI3K/AKT signaling pathways. In this study, we demonstrated that acerogenin A effectively prevents glutamate-induced oxidative damage, and HO-1 induction via PI3K/Akt and Nrf2 pathways appears to play a key role in the protection of HT22 cells. Therefore, this study implies that the Nrf2/HO-1 pathway represents a biological target and that acerogenin A might be a candidate for the prevention of neurodegeneration.

Indexed as

AnimalsCell LineCell NucleusCyclophanesCytosolDiarylheptanoidsGene Expression RegulationGlutamic AcidHeme Oxygenase-1HippocampusMembrane ProteinsMiceNeuronsNeuroprotective AgentsNF-E2-Related Factor 2Oxidative Stressacerogenin ACyclophanesDiarylheptanoidsGlutamic AcidHeme Oxygenase-1Hmox1 protein, mouseMembrane ProteinsNeuroprotective AgentsNfe2l2 protein, mouseNF-E2-Related Factor 2Phenyl EthersPhosphatidylinositol 3-KinasesPlant ExtractsProto-Oncogene Proteins c-aktReactive Oxygen SpeciesRNA, Small Interferingacerogenin Aheme oxygenase-1mouse hippocampal HT22 cellsneuro-protective effectsnuclear factor-E2-related factor 2

Identifiers

PMID26184139
PMCPMC6331826
OpenAlexW1872315482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.